Cytokine and Cytokine Receptor Single-Nucleotide Polymorphisms Predict Risk for Non–Small Cell Lung Cancer among Women
暂无分享,去创建一个
S. Land | J. Abrams | A. Schwartz | A. Wenzlaff | A. V. Van Dyke | M. Cote | Wei Chen | C. Giroux | Alison L Van Dyke
[1] J. Gutkind,et al. CXCL8/IL8 Stimulates Vascular Endothelial Growth Factor (VEGF) Expression and the Autocrine Activation of VEGFR2 in Endothelial Cells by Activating NFκB through the CBM (Carma3/Bcl10/Malt1) Complex* , 2009, Journal of Biological Chemistry.
[2] H. Mühl,et al. IFN-gamma Impairs Release of IL-8 by IL-1beta-stimulated A549 Lung Carcinoma Cells , 2008, BMC Cancer.
[3] F. Mihălțan,et al. Anti-TNF-α therapies in chronic obstructive pulmonary diseases , 2008 .
[4] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[5] A. Schwartz,et al. Regular Adult Aspirin Use Decreases the Risk of Non-Small Cell Lung Cancer among Women , 2008, Cancer Epidemiology Biomarkers & Prevention.
[6] Li Zhu,et al. IL-7 ENHANCES THE ANTI-TUMOR RESPONSE IN NON-SMALL CELL LUNG CANCER , 2007 .
[7] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[8] M. Spitz,et al. Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. , 2007, Cancer research.
[9] T. Mukherjee,et al. Role of TNFα in pulmonary pathophysiology , 2006, Respiratory Research.
[10] H. Kubo,et al. Interleukin-1beta gene polymorphisms associated with risk of lung cancer in Japanese. , 2006, Lung cancer.
[11] Thomas Lumley,et al. Simple estimates of haplotype relative risks in case‐control data , 2006, Genetic epidemiology.
[12] Amit Sharma,et al. Association of TNF haplotypes with asthma, serum IgE levels, and correlation with serum TNF-alpha levels. , 2006, American journal of respiratory cell and molecular biology.
[13] Ziv Bar-Joseph,et al. Evaluation of different biological data and computational classification methods for use in protein interaction prediction , 2006, Proteins.
[14] Ewa Wójcik,et al. Pretreatment Serum Levels of Cytokines and Cytokine Receptors in Patients with Non-Small Cell Lung Cancer, and Correlations with Clinicopathological Features and Prognosis , 2006, Oncology.
[15] Wei Chen,et al. Association of TNF-α polymorphism with susceptibility to and severity of non-small cell lung cancer , 2006 .
[16] J. Beebe-Dimmer,et al. Chronic Inflammation: A Common and Important Factor in the Pathogenesis of Neoplasia , 2006, CA: a cancer journal for clinicians.
[17] E. Feuer,et al. SEER Cancer Statistics Review, 1975-2003 , 2006 .
[18] S. Kajigaya,et al. Interferon-gamma-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles. , 2006, Blood.
[19] S. Kam,et al. Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study , 2006, BMC Cancer.
[20] M. Chou,et al. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer. , 2005, Lung cancer.
[21] F. Marincola,et al. Interleukin‐10 and the immune response against cancer: a counterpoint , 2005, Journal of leukocyte biology.
[22] Deborah Schrag,et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. , 2005, Journal of the National Cancer Institute.
[23] S. Khuder,et al. Nonsteroidal antiinflammatory drug use and lung cancer: a metaanalysis. , 2005, Chest.
[24] T. Waldmann,et al. Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance. , 2005, Blood.
[25] Jae Won Lee,et al. An extensive comparison of recent classification tools applied to microarray data , 2004, Comput. Stat. Data Anal..
[26] F. Tas,et al. Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer , 2005, Medical oncology.
[27] Jeremy J. W. Chen,et al. The role of interleukin-8 in cancer cells and microenvironment interaction. , 2005, Frontiers in bioscience : a journal and virtual library.
[28] R. Ness,et al. Differential distribution of allelic variants in cytokine genes among African Americans and White Americans. , 2004, American journal of epidemiology.
[29] D. McMillan,et al. The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer , 2004, British Journal of Cancer.
[30] R. Matalon,et al. Comprehensive analysis of genetic polymorphisms in the interleukin-10 promoter: implications for immune regulation in specific ethnic populations. , 2004, Genetic testing.
[31] A Senthilselvan,et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis , 2004, Thorax.
[32] E. Terzioğlu,et al. Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinoma. , 2004, Lung cancer.
[33] F. Canzian,et al. Polymorphisms of the interleukin‐1 β gene are associated with increased risk of non‐small cell lung cancer , 2004, International journal of cancer.
[34] Israel Rubinstein,et al. Markers of inflammation in exhaled breath condensate of young healthy smokers. , 2004, Chest.
[35] R. Radcliffe,et al. Tnfa and Il‐10 deficiencies have contrasting effects on lung tumor susceptibility: Gender‐dependent modulation of IL‐10 haploinsufficiency , 2003, Molecular carcinogenesis.
[36] H. Groen,et al. Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] K. Chow,et al. Cyclooxygenase-2 in human non-small cell lung cancer. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[38] D. Stojanovic,et al. Cytokines in Patients with Lung Cancer , 2003, Scandinavian journal of immunology.
[39] Jianfeng Xu,et al. Racial differences in selected cytokine allelic and genotypic frequencies among healthy, pregnant women in North Carolina. , 2003, Cytokine.
[40] M. Ryder,et al. Effects of tobacco smoke on the secretion of interleukin-1beta, tumor necrosis factor-alpha, and transforming growth factor-beta from peripheral blood mononuclear cells. , 2002, Oral microbiology and immunology.
[41] D. Harlan,et al. Ethnicity Greatly Influences Cytokine Gene Polymorphism Distribution , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[42] A. Urbano,et al. Interleukin-7 receptor expression and activation in nonhaematopoietic neoplastic cell lines. , 2002, Cellular signalling.
[43] S. Dudoit,et al. Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data , 2002 .
[44] D. Harlan,et al. Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. , 2001, Transplantation.
[45] S M Hanash,et al. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[46] K. Chung,et al. Cytokines in chronic obstructive pulmonary disease , 2001, European Respiratory Journal.
[47] S. Henikoff,et al. Predicting deleterious amino acid substitutions. , 2001, Genome research.
[48] S. Sone,et al. Interleukin (IL-)15 has less activity than IL-2 to promote type 2 cytokine predominance in tumour-associated mononuclear cells from lung cancer patients. , 2001, Cytokine.
[49] F. Yamasawa,et al. Increased expression of inflammatory mediators in small-airway epithelium from tobacco smokers. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[50] Michael T. Fisher,et al. Molecular determinants of response to TRAIL in killing of normal and cancer cells. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[51] A. Hamsten,et al. A Common Functional Polymorphism (C→A Substitution at Position −863) in the Promoter Region of the Tumour Necrosis Factor-α (TNF-α) Gene Associated With Reduced Circulating Levels of TNF-α , 1999 .
[52] 樋口 貴文. Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese , 1999 .
[53] F. Santolaria,et al. Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer. , 1999, Cytokine.
[54] A. Chapoval,et al. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells. , 1998, Journal of immunology.
[55] Y. Yatabe,et al. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. , 1998, Cancer research.
[56] A. Kimura,et al. Polymorphism of the 5′‐flanking region of the human tumor necrosis factor (TNF)‐α gene in Japanese , 1998 .
[57] W. Kuschner,et al. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. , 1996, The European respiratory journal.
[58] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[59] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[60] E. Bleecker,et al. Altered cytokine regulation in the lungs of cigarette smokers. , 1994, American journal of respiratory and critical care medicine.
[61] T. Standiford,et al. IL-7 up-regulates the expression of IL-8 from resting and stimulated human blood monocytes. , 1992, Journal of immunology.
[62] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.